BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523. [PMID: 23369416 DOI: 10.1016/j.jacc.2012.06.063] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
Number Citing Articles
1 Song L, Ding S, Ge Z, Zhu X, Qiu C, Wang Y, Lai E, Yang W, Sun Y, Chow SA, Yu L. Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells. Br J Pharmacol 2018;175:1241-59. [PMID: 28910489 DOI: 10.1111/bph.14036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
2 Joshi PH, Miller PE, Martin SS, Jones SR, Massaro JM, D'Agostino RB Sr, Kulkarni KR, Sponseller C, Toth PP. Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients. AIDS 2017;31:965-71. [PMID: 28121706 DOI: 10.1097/QAD.0000000000001423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Mirrakhimov AE, Ali AM, Barbaryan A, Prueksaritanond S. Human immunodeficiency virus and pulmonary arterial hypertension. ISRN Cardiol 2013;2013:903454. [PMID: 24027641 DOI: 10.1155/2013/903454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
4 Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 2016;30:1495-509. [PMID: 27058351 DOI: 10.1097/QAD.0000000000001109] [Cited by in Crossref: 104] [Cited by in F6Publishing: 61] [Article Influence: 17.3] [Reference Citation Analysis]
5 Bajdechi M, Gurghean A, Mateescu I, Zekra L, Rugină S. Coronary Artery Disease in People Living with Human Immunodeficiency Virus. Internal Medicine 2022;19:71-5. [DOI: 10.2478/inmed-2022-0209] [Reference Citation Analysis]
6 Schoepf IC, Buechel RR, Kovari H, Hammoud DA, Tarr PE. Subclinical Atherosclerosis Imaging in People Living with HIV. J Clin Med 2019;8:E1125. [PMID: 31362391 DOI: 10.3390/jcm8081125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
7 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Boccara F. Cardiovascular health in an aging HIV population. AIDS 2017;31 Suppl 2:S157-63. [PMID: 28471946 DOI: 10.1097/QAD.0000000000001384] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
9 Xu MM, Murphy PA, Vella AT. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation. Am J Physiol Heart Circ Physiol 2019;316:H1354-65. [PMID: 30925075 DOI: 10.1152/ajpheart.00148.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome. J Am Heart Assoc 2020;9:e017578. [PMID: 32844734 DOI: 10.1161/JAHA.119.017578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zwoliński R, Kamerys J, Jabłonowska E, Marcinkiewicz A, Jaszewski R, Kręcki R, Jegier B. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm. Kardiochir Torakochirurgia Pol 2017;14:211-3. [PMID: 29181053 DOI: 10.5114/kitp.2017.70539] [Reference Citation Analysis]
12 Hauguel-Moreau M, Boccara F, Boyd A, Salem JE, Brugier D, Curjol A, Hulot JS, Kerneis M, Galier S, Cohen A, Montalescot G, Collet JP, Silvain J. Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study. Eur Heart J 2017;38:1676-86. [PMID: 28065907 DOI: 10.1093/eurheartj/ehw583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
13 Sarkar S, Haberlen S, Post WS, Kelesidis T, Wiley D, Kingsley L, Kim E, Palella FJ, Witt MD, Budoff MJ, Rodriguez A, Brown TT. Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study. AIDS Research and Human Retroviruses 2021;37:842-5. [DOI: 10.1089/aid.2021.0035] [Reference Citation Analysis]
14 Bloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, Velazquez EJ. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infect Dis 2014;14:284. [PMID: 24886474 DOI: 10.1186/1471-2334-14-284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
15 Utama S, Patriawan P, Dewi A. Correlation of CD4/CD8 Ratio with Carotid Intima-Media Layer Thickness in HIV/AIDS Patients at Sanglah General Hospital, Bali, Indonesia. Open Access Maced J Med Sci 2019;7:1803-7. [PMID: 31316662 DOI: 10.3889/oamjms.2019.479] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Song G, Qiao W, Sun L, Yu X. A Meta-Analysis of Different Types of Cardiac Adipose Tissue in HIV Patients. Biomed Res Int 2020;2020:8234618. [PMID: 33376740 DOI: 10.1155/2020/8234618] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lagathu C, Béréziat V, Gorwood J, Fellahi S, Bastard JP, Vigouroux C, Boccara F, Capeau J. Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment. Expert Opin Drug Saf 2019;18:829-40. [PMID: 31304808 DOI: 10.1080/14740338.2019.1644317] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
18 Raposeiras-Roubín S, Triant V. Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk. Rev Esp Cardiol (Engl Ed) 2016;69:1204-13. [PMID: 27840147 DOI: 10.1016/j.rec.2016.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, Shoptaw S. Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depend 2019;195:164-9. [PMID: 30429048 DOI: 10.1016/j.drugalcdep.2018.06.036] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Karavidas A, Xylomenos G, Matzaraki V, Papoutsidakis N, Leventopoulos G, Farmakis D, Lazaros G, Perpinia A, Arapi S, Paisios N, Parissis J, Pyrgakis V, Gargalianos P. Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients. Clin Res Cardiol 2015;104:975-81. [PMID: 25977163 DOI: 10.1007/s00392-015-0866-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
21 Lawal IO, Stoltz AC, Sathekge MM. Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection. Clin Transl Imaging 2020;8:141-55. [DOI: 10.1007/s40336-020-00370-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wiggins BS, Lamprecht DG Jr, Page RL 2nd, Saseen JJ. Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications. Am J Cardiovasc Drugs 2017;17:375-89. [PMID: 28364370 DOI: 10.1007/s40256-017-0222-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
23 Strijdom H, De Boever P, Walzl G, Essop MF, Nawrot TS, Webster I, Westcott C, Mashele N, Everson F, Malherbe ST, Stanley K, Kessler HH, Stelzl E, Goswami N. Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa. BMC Infect Dis 2017;17:41. [PMID: 28061822 DOI: 10.1186/s12879-016-2158-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
24 Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, Mckenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. Journal of Clinical Lipidology 2015;9:S1-S122.e1. [DOI: 10.1016/j.jacl.2015.09.002] [Cited by in Crossref: 243] [Cited by in F6Publishing: 196] [Article Influence: 34.7] [Reference Citation Analysis]
25 Harris R. Promoting Cardiovascular Health in Patients Living with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Nurs Clin North Am 2018;53:47-56. [PMID: 29362060 DOI: 10.1016/j.cnur.2017.10.005] [Reference Citation Analysis]
26 Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL; investigators of the Canadian HIV and Aging Cohort Study. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol. BMC Infect Dis 2017;17:611. [PMID: 28893184 DOI: 10.1186/s12879-017-2692-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
27 Metkus TS, Brown T, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Jacobson LP, Post WS. HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS). HIV Med 2015;16:635-9. [PMID: 25968104 DOI: 10.1111/hiv.12262] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
28 Peyracchia M, De Lio G, Montrucchio C, Omedè P, d'Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D'Ascenzo F. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study. Atherosclerosis 2018;274:218-26. [PMID: 29803160 DOI: 10.1016/j.atherosclerosis.2018.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
29 Choi JY, Lui GCY, Liao CT, Yang CJ. Managing cardiovascular risk in people living with HIV in Asia - where are we now? HIV Med 2021. [PMID: 34494350 DOI: 10.1111/hiv.13164] [Reference Citation Analysis]
30 Bloomfield GS, Leung C. Cardiac Disease Associated with Human Immunodeficiency Virus Infection. Cardiol Clin 2017;35:59-70. [PMID: 27886790 DOI: 10.1016/j.ccl.2016.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
31 Tan BK, Chalouni M, Ceron DS, Cinaud A, Esterle L, Loko MA, Katlama C, Poizot-Martin I, Neau D, Chas J, Morlat P, Rosenthal E, Lacombe K, Naqvi A, Barange K, Bouchaud O, Gervais A, Lascoux-Combe C, Garipuy D, Alric L, Goujard C, Miailhes P, Aumaitre H, Duvivier C, Simon A, Lopez-Zaragoza JL, Zucman D, Raffi F, Lazaro E, Rey D, Piroth L, Boué F, Gilbert C, Bani-Sadr F, Dabis F, Sogni' P, Wittkop L, Boccara F; ANRS CO13 HEPAVIH study group. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clin Infect Dis 2021;72:e215-23. [PMID: 32686834 DOI: 10.1093/cid/ciaa1014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ng B, Macpherson P, Haddad T, Dwivedi G. Heart failure in HIV infection: focus on the role of atherosclerosis. Current Opinion in Cardiology 2014;29:174-9. [DOI: 10.1097/hco.0000000000000041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lai YJ, Chen YY, Huang HH, Ko MC, Chen CC, Yen YF. Incidence of cardiovascular diseases in a nationwide HIV/AIDS patient cohort in Taiwan from 2000 to 2014. Epidemiol Infect 2018;146:2066-71. [PMID: 30157970 DOI: 10.1017/S0950268818002339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
34 Zanet DL, Thorne A, Singer J, Maan EJ, Sattha B, Le Campion A, Soudeyns H, Pick N, Murray M, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA. Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy. Clin Infect Dis 2014;58:1322-32. [PMID: 24457340 DOI: 10.1093/cid/ciu051] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
35 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
36 Guénantin A, Briand N, Bidault G, Afonso P, Béréziat V, Vatier C, Lascols O, Caron-debarle M, Capeau J, Vigouroux C. Nuclear envelope-related lipodystrophies. Seminars in Cell & Developmental Biology 2014;29:148-57. [DOI: 10.1016/j.semcdb.2013.12.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
37 Volpe M, Uglietti A, Castagna A, Mussini C, Marchetti G, Bellagamba R, Bini T, Mancusi D, Termini R. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol 2017;241:50-6. [PMID: 28285796 DOI: 10.1016/j.ijcard.2017.02.117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Nadel J, Holloway CJ. Screening and risk assessment for coronary artery disease in HIV infection: an unmet need. HIV Med 2017;18:292-9. [PMID: 27553248 DOI: 10.1111/hiv.12422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
39 Pennefather C, Esterhuizen T, Doubell A, Decloedt EH. The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study. BMC Infect Dis 2021;21:657. [PMID: 34233630 DOI: 10.1186/s12879-021-06367-2] [Reference Citation Analysis]
40 Chen Y, Gao Y, Zhou Y, Li X, Wang H, Polonsky TS, Vermund SH, Qian HZ, Qian F. Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies. J Acquir Immune Defic Syndr 2021;87:741-9. [PMID: 33492019 DOI: 10.1097/QAI.0000000000002629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wagle A, Goerlich E, Post WS, Woldu B, Wu KC, Hays AG. HIV and Global Cardiovascular Health. Curr Cardiol Rep 2022. [PMID: 35802233 DOI: 10.1007/s11886-022-01741-1] [Reference Citation Analysis]
42 Mondal P, Aljizeeri A, Small G, Malhotra S, Harikrishnan P, Affandi JS, Buechel RR, Dwivedi G, Al-Mallah MH, Jain D. Coronary artery disease in patients with human immunodeficiency virus infection. J Nucl Cardiol 2021;28:510-30. [PMID: 32820424 DOI: 10.1007/s12350-020-02280-4] [Reference Citation Analysis]
43 Guaraldi G, Luzi K, Bellistrì GM, Zona S, Domingues da Silva AR, Bai F, Garlassi E, Marchetti G, Capeau J, Monforte Ad. CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients. J Acquir Immune Defic Syndr 2013;64:360-6. [PMID: 24129368 DOI: 10.1097/QAI.0000000000000001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
44 Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11:728-741. [PMID: 25331088 DOI: 10.1038/nrcardio.2014.167] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
45 Auclair M, Guénantin AC, Fellahi S, Garcia M, Capeau J. HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells. PLoS One 2020;15:e0226924. [PMID: 31971958 DOI: 10.1371/journal.pone.0226924] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
46 Ghasemzadeh N, Zhang L, Al Mheid I, Li Q, Sperling L, Waller EK, Taylor WR, Guest J, Quyyumi AA, Mavromatis K. Circulating progenitor cells are reduced in HIV-positive, anti-retroviral naïve patients. Int J Cardiol 2014;176:1150-2. [PMID: 25175523 DOI: 10.1016/j.ijcard.2014.07.282] [Reference Citation Analysis]
47 Lawal IO, Ankrah AO, Popoola GO, Lengana T, Sathekge MM. Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT. J Nucl Cardiol 2019;26:1258-65. [PMID: 29417417 DOI: 10.1007/s12350-018-1207-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
48 Srinivasa S, Lu MT, Fitch KV, Hallett TR, O'Malley TK, Stone LA, Martin A, Coromilas AJ, Burdo TH, Triant VA, Lo J, Looby SE, Neilan TG, Zanni MV. Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIV. Antivir Ther 2018;23:1-9. [PMID: 28930079 DOI: 10.3851/IMP3193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
49 Pastori D, Esposito A, Carnevale R, Bartimoccia S, Novo M, Fantauzzi A, Di Campli F, Pignatelli P, Violi F, Mezzaroma I. HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. Journal of Infection 2015;70:651-8. [DOI: 10.1016/j.jinf.2015.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
50 Tsai FJ, Li TM, Cheng CF, Wu YC, Lai CH, Ho TJ, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin JC, Lin CC, Liang WM, Lin YJ. Effects of Chinese herbal medicine on hyperlipidemia and the risk of cardiovascular disease in HIV-infected patients in Taiwan. J Ethnopharmacol 2018;219:71-80. [PMID: 29530610 DOI: 10.1016/j.jep.2018.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
51 Escárcega RO, Franco JJ, Mani BC, Vyas A, Tedaldi EM, Bove AA. Cardiovascular disease in patients with chronic human immunodeficiency virus infection. International Journal of Cardiology 2014;175:1-7. [DOI: 10.1016/j.ijcard.2014.04.155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
52 Arrive E, Viard JP, Salanave B, Dollfus C, Matheron S, Reliquet V, Arezes E, Nailler L, Vigouroux C, Warszawski J; ANRS CO19 COVERTE and ENNS study groups. Metabolic risk factors in young adults infected with HIV since childhood compared with the general population. PLoS One 2018;13:e0206745. [PMID: 30408056 DOI: 10.1371/journal.pone.0206745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
53 Deshpande A, Toshniwal H, Joshi S, Jani RH. A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy. PLoS One 2016;11:e0146222. [PMID: 26789842 DOI: 10.1371/journal.pone.0146222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Okeke NL, Alenezi F, Bloomfield GS, Dunning A, Clement ME, Shah SH, Naggie S, Velazquez EJ. Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. J Card Fail 2018;24:496-503. [PMID: 29964194 DOI: 10.1016/j.cardfail.2018.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
55 Rosenson RS, Colantonio LD, Burkholder GA, Chen L, Muntner P. Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015. J Am Heart Assoc 2018;7:e010345. [PMID: 30526249 DOI: 10.1161/JAHA.118.010345] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
56 Leite LHM, Cohen A, Boccara F. HIV infection and aortic stiffness. Arch Cardiovasc Dis 2017;110:495-502. [PMID: 28416296 DOI: 10.1016/j.acvd.2017.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Loens C, Amet S, Isnard-Bagnis C, Deray G, Tourret J. [Nephrotoxicity of antiretrovirals other than tenofovir]. Nephrol Ther 2018;14:55-66. [PMID: 29500080 DOI: 10.1016/j.nephro.2017.12.001] [Reference Citation Analysis]
58 Stosor V. Organ Transplantation in HIV Patients: Current Status and New Directions. Curr Infect Dis Rep 2013;15:526-35. [PMID: 24142801 DOI: 10.1007/s11908-013-0381-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
59 Bruder-Nascimento T, Kress TC, Kennard S, Belin de Chantemèle EJ. HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH Oxidase 1 (Nox1), C-C Chemokine Receptor Type 5 (CCR5), and Inflammation. J Am Heart Assoc 2020;9:e018074. [PMID: 33003981 DOI: 10.1161/JAHA.120.018074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zanni MV, Fitch KV, Feldpausch M, Han A, Lee H, Lu MT, Abbara S, Ribaudo H, Douglas PS, Hoffmann U, Lo J, Grinspoon SK. 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque. AIDS 2014;28:2061-70. [PMID: 25265074 DOI: 10.1097/QAD.0000000000000360] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 7.1] [Reference Citation Analysis]
61 Jeudy J, Patel P, George N, Burrowes S, Husson J, Chua J, Conn L, Weiss RG, Bagchi S. Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection. AIDS 2022;36:399-407. [PMID: 34750294 DOI: 10.1097/QAD.0000000000003125] [Reference Citation Analysis]
62 Domingo P, Mateo MG, Villarroya J, Cereijo R, Torres F, Domingo JC, Campderrós L, Gallego-Escuredo JM, Gutierrez MDM, Mur I, Corbacho N, Vidal F, Villarroya F, Giralt M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. J Clin Med 2022;11:549. [PMID: 35160008 DOI: 10.3390/jcm11030549] [Reference Citation Analysis]
63 Williams C, Kamau FM, Everson F, Kgokane B, De Boever P, Goswami N, Webster I, Strijdom H. HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South Africa. J Clin Med 2021;10:4112. [PMID: 34575223 DOI: 10.3390/jcm10184112] [Reference Citation Analysis]
64 Chaudhary NS, Kind T, Willig AL, Saag MS, Shrestha S, Funderburg N, Wiener HW, Overton ET, Irvin MR. Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study. Medicine (Baltimore) 2021;100:e26588. [PMID: 34397689 DOI: 10.1097/MD.0000000000026588] [Reference Citation Analysis]
65 Stone L, Looby SE, Zanni MV. Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS 2017;12:585-93. [PMID: 28832367 DOI: 10.1097/COH.0000000000000413] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
66 Peyracchia M, Verardi R, Rubin SR, Abu-Assi E, Montrucchio C, Perl L, Grossomarra W, Calcagno A, Omedè P, Montefusco A, Bonora S, Moretti C, D'Amico M, Mauro R, D'Ascenzo F. In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis. J Cardiovasc Med (Hagerstown) 2019;20:321-6. [PMID: 30664538 DOI: 10.2459/JCM.0000000000000767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
67 Larson D, Won SH, Ganesan A, Maves RC, Kronmann K, Okulicz JF, Chu X, Schofield C, O'Bryan T, Agan BK, Deiss R. Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study. HIV Med 2021. [PMID: 34704330 DOI: 10.1111/hiv.13195] [Reference Citation Analysis]
68 Sood V, Jermy S, Saad H, Samuels P, Moosa S, Ntusi N. Review of cardiovascular magnetic resonance in human immunodeficiency virus-associated cardiovascular disease. SA J Radiol 2017;21:1248. [PMID: 31754483 DOI: 10.4102/sajr.v21i2.1248] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
69 Cannillo M, D'Ascenzo F, Grosso Marra W, Cerrato E, Calcagno A, Omedè P, Bonora S, Mancone M, Vizza D, DiNicolantonio JJ, Pianelli M, Barbero U, Gili S, Annone U, Raviola A, Salera D, Mistretta E, Vilardi I, Colaci C, Abbate A, Zoccai GB, Moretti C, Gaita F. Heart failure in patients with human immunodeficiency virus: a review of the literature. J Cardiovasc Med (Hagerstown) 2015;16:383-9. [PMID: 25058690 DOI: 10.2459/JCM.0000000000000168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
70 Tincati C, Mondatore D, Bai F, d'Arminio Monforte A, Marchetti G. Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles? Open Forum Infect Dis 2020;7:ofaa340. [PMID: 33005694 DOI: 10.1093/ofid/ofaa340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Moulignier A, Costagliola D. Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders. Curr Top Behav Neurosci 2021;50:367-99. [PMID: 31989463 DOI: 10.1007/7854_2019_123] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Marsousi N, Daali Y, Fontana P, Reny JL, Ancrenaz-Sirot V, Calmy A, Rudaz S, Desmeules JA, Samer CF. Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. Clin Pharmacokinet 2018;57:1347-54. [PMID: 29453687 DOI: 10.1007/s40262-018-0637-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
73 Todd JV, Cole SR, Wohl DA, Simpson RJ Jr, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, Adimora AA. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. AIDS Patient Care STDS 2017;31:447-54. [PMID: 29087746 DOI: 10.1089/apc.2017.0145] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
74 Boldeanu I, Sadouni M, Mansour S, Baril JG, Trottier B, Soulez G, S Chin A, Leipsic J, Tremblay C, Durand M, Chartrand-Lefebvre C; Canadian HIV and Aging Cohort Study Group. Prevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort Study. Radiology 2021;299:571-80. [PMID: 33876969 DOI: 10.1148/radiol.2021203297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Afonso P, Auclair M, Boccara F, Vantyghem M, Katlama C, Capeau J, Vigouroux C, Caron-debarle M. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation. Atherosclerosis 2016;245:200-11. [DOI: 10.1016/j.atherosclerosis.2015.12.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
76 Hamilton AB, Brown A, Loeb T, Chin D, Grills C, Cooley-Strickland M, Liu HH, Wyatt GE. Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol. Prog Cardiovasc Dis 2020;63:101-8. [PMID: 32109483 DOI: 10.1016/j.pcad.2020.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Guerreiro da Silva Júnior N, Pedreira EN, Tuji FM, Warmling LV, Ortega KL. Prevalence of calcified carotid artery atheromas in panoramic radiographs of HIV-positive patients undergoing antiretroviral treatment: a retrospective study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2014;117:67-74. [DOI: 10.1016/j.oooo.2013.08.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
78 Negredo E, Back D, Blanco JR, Blanco J, Erlandson KM, Garolera M, Guaraldi G, Mallon P, Moltó J, Serra JA, Clotet B. Aging in HIV-Infected Subjects: A New Scenario and a New View. Biomed Res Int 2017;2017:5897298. [PMID: 29430462 DOI: 10.1155/2017/5897298] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
79 Cheruvu S, Holloway CJ. Cardiovascular disease in human immunodeficiency virus. Intern Med J 2014;44:315-24. [PMID: 24754684 DOI: 10.1111/imj.12381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
80 Kelesidis T, Currier JS. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am 2014;43:665-84. [PMID: 25169560 DOI: 10.1016/j.ecl.2014.06.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
81 Schwetz TA, Fauci AS. The Extended Impact of Human Immunodeficiency Virus/AIDS Research. J Infect Dis 2019;219:6-9. [PMID: 30165415 DOI: 10.1093/infdis/jiy441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
82 Madan S, Patel SR, Saeed O, Sims DB, Shin JJ, Goldstein DJ, Jorde UP. Outcomes of heart transplantation in patients with human immunodeficiency virus. Am J Transplant 2019;19:1529-35. [PMID: 30614612 DOI: 10.1111/ajt.15257] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
83 Barocas JA, Erlandson KM, Belzer BK, Hess T, Sosman J. Advance directives among people living with HIV: room for improvement. AIDS Care 2015;27:370-7. [PMID: 25307722 DOI: 10.1080/09540121.2014.963019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
84 Longenecker CT, Eckard AR, McComsey GA. Statins to improve cardiovascular outcomes in treated HIV infection. Curr Opin Infect Dis 2016;29:1-9. [PMID: 26658651 DOI: 10.1097/QCO.0000000000000223] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
85 Sharma P, Kabach M, Sehatbakhsh S, Tharpe R, Isaac S, Chait R, De Almeida K. Non-ST Elevation Myocardial Infarction and Severe Peripheral Artery Disease in a 20-Year-Old with Perinatally Acquired Human Immunodeficiency Virus Infection. Case Rep Infect Dis 2018;2018:7803406. [PMID: 29808134 DOI: 10.1155/2018/7803406] [Reference Citation Analysis]
86 Khawaja AA, Taylor KA, Lovell AO, Nelson M, Gazzard B, Boffito M, Emerson M. HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk. Circ Res 2020;127:1365-80. [PMID: 32998637 DOI: 10.1161/CIRCRESAHA.119.316477] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
87 Vos A, Tempelman H, Devillé W, Barth R, Wensing A, Kretzschmar M, Klipstein-Grobusch K, Hoepelman A, Tesselaar K, Aitken S, Madzivhandila M, Uiterwaal C, Venter F, Coutinho R, Grobbee DE. HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study. Eur J Prev Cardiol 2017;24:1043-50. [PMID: 28379043 DOI: 10.1177/2047487317702039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
88 Boccara F, Kumar P, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics. Am Heart J 2020;220:203-12. [PMID: 31841795 DOI: 10.1016/j.ahj.2019.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Peprah E, Caler E, Snyder A, Ketema F. Deconstructing Syndemics: The Many Layers of Clustering Multi-Comorbidities in People Living with HIV. Int J Environ Res Public Health 2020;17:E4704. [PMID: 32629920 DOI: 10.3390/ijerph17134704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Bagchi S, Burrowes SA, Fantry LE, Hossain MB, Tollera GH, Kottilil S, Pauza CD, Miller M, Baumgarten M, Redfield RR. Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population. SAGE Open Med 2017;5:2050312117725644. [PMID: 28839941 DOI: 10.1177/2050312117725644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Pushkarsky T, Shilov E, Kruglova N, Naumann R, Brichacek B, Jennelle L, Sviridov D, Kruglov A, Nedospasov SA, Bukrinsky M. Short Communication: Accumulation of Neutral Lipids in Liver and Aorta of Nef-Transgenic Mice. AIDS Res Hum Retroviruses 2017;33:57-60. [PMID: 27649790 DOI: 10.1089/AID.2016.0128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
92 Bassendine MF, Nielsen SU, Bridge SH, Felmlee DJ, Sheridan DA, Packard CJ, Neely RD. Hepatitis C virus and atherosclerosis: A legacy after virologic cure? Clin Res Hepatol Gastroenterol 2017;41:25-30. [PMID: 27840032 DOI: 10.1016/j.clinre.2016.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
93 Elahi S, Weiss RH, Merani S. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. AIDS 2016;30:171-83. [PMID: 26645604 DOI: 10.1097/QAD.0000000000000917] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
94 Iantorno M, Schär M, Soleimanifard S, Brown TT, Moore R, Barditch-Crovo P, Stuber M, Lai S, Gerstenblith G, Weiss RG, Hays AG. Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease. AIDS 2017;31:1281-9. [PMID: 28353539 DOI: 10.1097/QAD.0000000000001469] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
95 Remick J, Georgiopoulou V, Marti C, Ofotokun I, Kalogeropoulos A, Lewis W, Butler J. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation 2014;129:1781-9. [PMID: 24778120 DOI: 10.1161/CIRCULATIONAHA.113.004574] [Cited by in Crossref: 84] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
96 Lidón F, Padilla S, García JA, Fernández M, García J, Ortiz de la Tabla V, Gutiérrez F, Masiá M. Contribution of Human Herpesvirus 8 and Herpes Simplex Type 2 to Progression of Carotid Intima-Media Thickness in People Living With HIV. Open Forum Infect Dis 2019;6:ofz041. [PMID: 30815506 DOI: 10.1093/ofid/ofz041] [Reference Citation Analysis]
97 Ngo-Matip ME, Pieme CA, Azabji-Kenfack M, Biapa PC, Germaine N, Heike E, Moukette BM, Emmanuel K, Philippe S, Mbofung CM, Ngogang JY. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study. Lipids Health Dis 2014;13:191. [PMID: 25496727 DOI: 10.1186/1476-511X-13-191] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
98 Sousos N, Gavriilaki E, Vakalopoulou S, Garipidou V. Understanding cardiovascular risk in hemophilia: A step towards prevention and management. Thrombosis Research 2016;140:14-21. [DOI: 10.1016/j.thromres.2016.02.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
99 Feinstein MJ, Achenbach CJ, Stone NJ, Lloyd-Jones DM. A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients. Am J Cardiol 2015;115:1760-6. [PMID: 25907504 DOI: 10.1016/j.amjcard.2015.03.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
100 Ogunbayo GO, Ha LD, Ahmad Q, Misumida N, Okwechime R, Elbadawi A, Abdel-Latif A, Elayi CS, Smyth S, Boccara F, Messerli AW. Treatment Bias in Management of HIV Patients Admitted for Acute Myocardial Infarction: Does It Still Exist? J Gen Intern Med 2020;35:57-62. [PMID: 31713036 DOI: 10.1007/s11606-019-05416-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
101 Polanco A, Itagaki S, Chiang Y, Chikwe J. Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States. Am Heart J 2014;167:363-8. [PMID: 24576521 DOI: 10.1016/j.ahj.2013.09.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
102 Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35:1373-1381. [PMID: 24408888 DOI: 10.1093/eurheartj/eht528] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 15.9] [Reference Citation Analysis]
103 Heron SE, Elahi S. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. Front Immunol 2017;8:241. [PMID: 28326084 DOI: 10.3389/fimmu.2017.00241] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
104 de Boissieu P, Dramé M, Raffi F, Cabie A, Poizot-Martin I, Cotte L, Garraffo R, Delobel P, Huleux T, Rey D, Bani-Sadr F; Dat’AIDS Study Group. Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study. Medicine (Baltimore) 2016;95:e4890. [PMID: 27631261 DOI: 10.1097/MD.0000000000004890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
105 Nell TA, Kruger MJ, Beukes DC, Calitz E, Essop R, Essop MF. Distinct gender differences in anthropometric profiles of a peri-urban South African HIV population: a cross sectional study. BMC Infect Dis 2015;15:85. [PMID: 25887844 DOI: 10.1186/s12879-015-0836-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
106 Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging 2014;7:515-25. [PMID: 24831212 DOI: 10.1016/j.jcmg.2013.08.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
107 Hentzien M, Dramé M, Allavena C, Jacomet C, Valantin MA, Cabié A, Cuzin L, Rey D, Pugliese P, Bani-Sadr F; Dat'AIDS Study Group. Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease. J Nutr Health Aging 2016;20:408-14. [PMID: 26999241 DOI: 10.1007/s12603-015-0608-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
108 Boccara F, Cohen A. HIV and Heart Disease: What Cardiologists Should Know. Rev Esp Cardiol (Engl Ed) 2016;69:1126-30. [PMID: 27553286 DOI: 10.1016/j.rec.2016.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Lumsden RH, Bloomfield GS. The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds. Biomed Res Int 2016;2016:8196560. [PMID: 26885518 DOI: 10.1155/2016/8196560] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
110 Tang N, Sun B, Gupta A, Rempel H, Pulliam L. Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells. FASEB J 2016;30:3097-106. [PMID: 27226520 DOI: 10.1096/fj.201600368RR] [Cited by in Crossref: 91] [Cited by in F6Publishing: 63] [Article Influence: 15.2] [Reference Citation Analysis]
111 Ruscica M, Tokgözoğlu L, Corsini A, Sirtori CR. PCSK9 inhibition and inflammation: A narrative review. Atherosclerosis 2019;288:146-55. [PMID: 31404822 DOI: 10.1016/j.atherosclerosis.2019.07.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
112 Raposeiras-roubín S, Triant V. Cardiopatía isquémica en el VIH: profundizando en el conocimiento del riesgo cardiovascular. Revista Española de Cardiología 2016;69:1204-13. [DOI: 10.1016/j.recesp.2016.08.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
113 Metkus TS, Timpone J, Leaf D, Bidwell Goetz M, Harris WS, Brown TT. Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients. HIV Med 2013;14:530-9. [PMID: 23683266 DOI: 10.1111/hiv.12046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
114 Tsabedze N, Vachiat A, Zachariah D, Manga P. A New Face of Cardiac Emergencies: Human Immunodeficiency Virus-Related Cardiac Disease. Cardiol Clin 2018;36:161-70. [PMID: 29173676 DOI: 10.1016/j.ccl.2017.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
115 Metkus TS Jr, Brown TT, Post WS. Cardiovascular disease associated with the human immunodeficiency virus: an update. Curr Treat Options Cardiovasc Med 2014;16:346. [PMID: 25193559 DOI: 10.1007/s11936-014-0346-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
116 Cybula-Walczak A, Szymanski FM, Platek AE, Karpinski G. Myocardial infarction type 4b in human immunodeficiency virus-infected patient. Korean Circ J 2014;44:42-4. [PMID: 24497889 DOI: 10.4070/kcj.2014.44.1.42] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Liu CH, Abrams ND, Carrick DM, Chander P, Dwyer J, Hamlet MRJ, Kindzelski AL, PrabhuDas M, Tsai SA, Vedamony MM, Wang C, Tandon P. Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities. FASEB J 2019;33:13085-97. [PMID: 31577913 DOI: 10.1096/fj.201902024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
118 Pham TV, Torres M. Human Immunodeficiency Virus Infection-Related Heart Disease. Emerg Med Clin North Am 2015;33:613-22. [PMID: 26226869 DOI: 10.1016/j.emc.2015.04.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
119 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
120 O'Dwyer EJ, Bhamra-Ariza P, Rao S, Emmanuel S, Carr A, Holloway CJ. Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome. Open Heart 2016;3:e000511. [PMID: 28123757 DOI: 10.1136/openhrt-2016-000511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
121 Dillon SM, Lee EJ, Kotter CV, Austin GL, Dong Z, Hecht DK, Gianella S, Siewe B, Smith DM, Landay AL. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 2014;7:983-994. [PMID: 24399150 DOI: 10.1038/mi.2013.116] [Cited by in Crossref: 260] [Cited by in F6Publishing: 265] [Article Influence: 32.5] [Reference Citation Analysis]
122 Eckard AR, Fowler SL, Haston JC, Dixon TC. Complications of Treatment in Youth with HIV. Curr HIV/AIDS Rep 2016;13:226-33. [PMID: 27234970 DOI: 10.1007/s11904-016-0320-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
123 Boccara F, Cohen A. VIH y cardiopatía: ¿qué deben saber los cardiólogos? Revista Española de Cardiología 2016;69:1126-30. [DOI: 10.1016/j.recesp.2016.05.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
124 Boccara F, Miantezila Basilua J, Mary-Krause M, Lang S, Teiger E, Steg PG, Funck-Brentano C, Girard PM, Costagliola D, Cohen A, Guiguet M; on behalf the PACS-HIV investigators (Prognosis of Acute Coronary Syndrome in HIV-infected patients). Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy. Am Heart J 2017;183:91-101. [PMID: 27979047 DOI: 10.1016/j.ahj.2016.10.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
125 Sarkar S, Haberlen S, Whelton S, E Schneider E, Kingsley L, Palella F, Witt MD, Kelesidis T, Rodriguez A, Post WS, Brown TT. Greater IL-6, D-dimer, and ICAM-1 Levels Are Associated With Lower Small HDL Particle Concentration in the Multicenter AIDS Cohort Study. Open Forum Infect Dis 2019;6:ofz474. [PMID: 32128324 DOI: 10.1093/ofid/ofz474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Whiteside YO, Selik R, An Q, Huang T, Karch D, Hernandez AL, Hall HI. Comparison of Rates of Death Having any Death-Certificate Mention of Heart, Kidney, or Liver Disease Among Persons Diagnosed with HIV Infection with those in the General US Population, 2009-2011. Open AIDS J 2015;9:14-22. [PMID: 25767634 DOI: 10.2174/1874613601509010014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
127 Nkambule BB, Davison G, Ipp H. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection. Platelets 2015;26:250-7. [PMID: 24831969 DOI: 10.3109/09537104.2014.909021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
128 Agarwal S, Agarwal SK. Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovasc Drugs Ther 2021;35:427-40. [PMID: 32918656 DOI: 10.1007/s10557-020-07070-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
129 Sinha A, Ma Y, Scherzer R, Hur S, Li D, Ganz P, Deeks SG, Hsue PY. Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV. J Am Heart Assoc 2016;5:e004243. [PMID: 27998918 DOI: 10.1161/JAHA.116.004243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
130 Boccara F, Cohen A. Immune activation and coronary atherosclerosis in HIV-infected women: where are we now, and where will we go next? J Infect Dis 2013;208:1729-31. [PMID: 24041798 DOI: 10.1093/infdis/jit511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
131 Tsoukas C. Immunosenescence and aging in HIV: . Current Opinion in HIV and AIDS 2014;9:398-404. [DOI: 10.1097/coh.0000000000000077] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
132 Secemsky EA, Scherzer R, Nitta E, Wu AH, Lange DC, Deeks SG, Martin JN, Snider J, Ganz P, Hsue PY. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals. JACC Heart Fail 2015;3:591-9. [PMID: 26164679 DOI: 10.1016/j.jchf.2015.03.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
133 Westman G, Berglund D, Widén J, Ingelsson M, Korsgren O, Lannfelt L, Sehlin D, Lidehall AK, Eriksson BM. Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's disease. PLoS One 2014;9:e96779. [PMID: 24804776 DOI: 10.1371/journal.pone.0096779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
134 Lang S, Boccara F, Mary-krause M, Cohen A. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries. Archives of Cardiovascular Diseases 2015;108:206-15. [DOI: 10.1016/j.acvd.2015.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
135 Burrowes S, Cahill P, Kottilil S, Bagchi S. Contribution of antiretroviral therapy to cardiovascular disease risk in HIV-infected patients. Future Virology 2016;11:509-27. [DOI: 10.2217/fvl-2016-0047] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
136 Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, Azzalini L. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol 2018;265:195-203. [PMID: 29885686 DOI: 10.1016/j.ijcard.2018.03.137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
137 Vachiat A, Mccutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and Ischemic Heart Disease. Journal of the American College of Cardiology 2017;69:73-82. [DOI: 10.1016/j.jacc.2016.09.979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
138 Hinojosa CA, Nunez-Salgado AE, Anaya-Ayala JE, Laparra-Escareno H, Ortiz-Lopez LJ, Herrera-Caceres JO, Crabtree-Ramirez BE, Sierra-Madero JG. Prevalence and variables associated with an abnormal ankle-brachial index among patients with human immunodeficiency virus/acquired immunodeficiency syndrome. Vascular 2018;26:540-6. [PMID: 29649953 DOI: 10.1177/1708538118770542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
139 Boccara F, Cohen A. How to identify HIV-infected individuals at risk for atherosclerotic events? AIDS 2014;28:2153-5. [PMID: 25265079 DOI: 10.1097/QAD.0000000000000416] [Reference Citation Analysis]
140 Aurpibul L, Srithanaviboonchai K, Rerkasem K, Tangmunkongvorakul A, Sitthi W, Musumari PM. Prevalence of Subclinical Atherosclerosis and Risk of Atherosclerotic Cardiovascular Disease in Older Adults Living with HIV. AIDS Res Hum Retroviruses 2019;35:1136-42. [PMID: 31382762 DOI: 10.1089/AID.2019.0023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
141 Theron AJ, Anderson R, Rossouw TM, Steel HC. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders. Front Immunol 2017;8:1461. [PMID: 29163528 DOI: 10.3389/fimmu.2017.01461] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
142 Antony I, Kannichamy V, Banerjee A, Gandhi AB, Valaiyaduppu Subas S, Hamid P. An Outlook on the Impact of HIV Infection and Highly Active Antiretroviral Therapy on the Cardiovascular System - A Review. Cureus 2020;12:e11539. [PMID: 33354483 DOI: 10.7759/cureus.11539] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Kaplan-Lewis E, Aberg JA, Lee M. Aging with HIV in the ART era. Semin Diagn Pathol 2017;34:384-97. [PMID: 28552209 DOI: 10.1053/j.semdp.2017.04.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
144 Bernelli C, Danzi GB, Cerrato E, Pierini S, Ornaghi MG, Botta L, Gentile F, Migliorino GM, Squillace N. Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease. Can J Cardiol 2020;36:127-34. [PMID: 31813674 DOI: 10.1016/j.cjca.2019.07.636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Stein JH, Kime N, Korcarz CE, Ribaudo H, Currier JS, Delaney JC. Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis. Arterioscler Thromb Vasc Biol 2021;41:512-22. [PMID: 33327750 DOI: 10.1161/ATVBAHA.120.315435] [Reference Citation Analysis]
146 Koganti S, Kinloch-de Loes S, Hutchinson S, Johnson M, Rakhit RD. Management of cardiovascular conditions in a cohort of patients with HIV: experience from a joint HIV/cardiology clinic. Clin Med (Lond) 2015;15:442-6. [PMID: 26430182 DOI: 10.7861/clinmedicine.15-5-442] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
147 Longenecker CT, Jiang Y, Orringer CE, Gilkeson RC, Debanne S, Funderburg NT, Lederman MM, Storer N, Labbato DE, McComsey GA. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS 2014;28:969-77. [PMID: 24691204 DOI: 10.1097/QAD.0000000000000158] [Cited by in Crossref: 100] [Cited by in F6Publishing: 81] [Article Influence: 12.5] [Reference Citation Analysis]
148 Boyd A, Boccara F, Meynard JL, Ichou F, Bastard JP, Fellahi S, Samri A, Sauce D, Haddour N, Autran B, Cohen A, Girard PM, Capeau J; Collaboration in HIV, Inflammation and Cardiovascular Disease study. Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults. Open Forum Infect Dis 2019;6:ofz516. [PMID: 31890722 DOI: 10.1093/ofid/ofz516] [Reference Citation Analysis]
149 Idris NS, Grobbee DE, Burgner D, Cheung MM, Kurniati N, Sastroasmoro S, Uiterwaal CS. Cardiovascular manifestations of HIV infection in children. Eur J Prev Cardiol 2015;22:1452-61. [PMID: 25398702 DOI: 10.1177/2047487314560086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
150 Iantorno M, Soleimanifard S, Schär M, Brown TT, Bonanno G, Barditch-Crovo P, Mathews L, Lai S, Gerstenblith G, Weiss RG, Hays AG. Regional coronary endothelial dysfunction is related to the degree of local epicardial fat in people with HIV. Atherosclerosis 2018;278:7-14. [PMID: 30227267 DOI: 10.1016/j.atherosclerosis.2018.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
151 Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus: PCI in Patients with HIV. Cathet Cardiovasc Intervent 2015;85:192-8. [DOI: 10.1002/ccd.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
152 Mongardon N, Geri G, Deye N, Sonneville R, Boissier F, Perbet S, Camous L, Lemiale V, Thirion M, Mathonnet A, Argaud L, Bodson L, Gaudry S, Kimmoun A, Legriel S, Lerolle N, Luis D, Luyt CE, Mayaux J, Guidet B, Pène F, Mira JP, Cariou A. Etiologies, clinical features and outcome of cardiac arrest in HIV-infected patients. Int J Cardiol 2015;201:302-7. [PMID: 26301665 DOI: 10.1016/j.ijcard.2015.08.055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
153 Martín-Cañavate R, Sonego M, Sagrado MJ, Escobar G, Rivas E, Ayala S, Castaneda L, Aparicio P, Custodio E. Dietary patterns and nutritional status of HIV-infected children and adolescents in El Salvador: A cross-sectional study. PLoS One 2018;13:e0196380. [PMID: 29763418 DOI: 10.1371/journal.pone.0196380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
154 Desvarieux M, Boccara F, Meynard JL, Bastard JP, Mallat Z, Charbit B, Demmer RT, Haddour N, Fellahi S, Tedgui A, Cohen A, Capeau J, Boyd A, Girard PM. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. AIDS 2013;27:2603-14. [PMID: 24100713 DOI: 10.1097/QAD.0b013e3283634819] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
155 Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S. Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease. J Am Coll Cardiol 2015;65:738-44. [PMID: 25677433 DOI: 10.1016/j.jacc.2014.12.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
156 Tiarukkitsagul J, Sungkanuparph S. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting. Int J STD AIDS 2021;32:421-6. [PMID: 33533302 DOI: 10.1177/0956462420972855] [Reference Citation Analysis]
157 Bloomfield GS, Velazquez EJ. HIV and cardiovascular disease in sub-Saharan Africa: the Sutton Law as applied to global health. J Am Coll Cardiol 2013;61:2395. [PMID: 23524216 DOI: 10.1016/j.jacc.2013.02.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
158 Pinto DSM, da Silva MJLV. Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection. Curr Cardiol Rev 2018;14:25-41. [PMID: 29189172 DOI: 10.2174/1573403X13666171129170046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
159 Idris NS, Grobbee DE, Burgner D, Cheung MM, Kurniati N, Uiterwaal CS. Effects of paediatric HIV infection on childhood vasculature. Eur Heart J 2016;37:3610-6. [PMID: 26746627 DOI: 10.1093/eurheartj/ehv702] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
160 Senoner T, Barbieri F, Adukauskaite A, Sarcletti M, Plank F, Beyer C, Dichtl W, Feuchtner GM. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography. AIDS 2019;33:1853-62. [PMID: 31259763 DOI: 10.1097/QAD.0000000000002297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
161 Cohen JA, Govea A, Carrillo RG. Clinical Outcomes of Patients with HIV Undergoing Lead Extraction for Infectious and Noninfectious Indications. Pacing Clin Electrophysiol 2016;39:122-7. [PMID: 26514095 DOI: 10.1111/pace.12773] [Reference Citation Analysis]
162 Lozupone CA, Li M, Campbell TB, Flores SC, Linderman D, Gebert MJ, Knight R, Fontenot AP, Palmer BE. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013;14:329-339. [PMID: 24034618 DOI: 10.1016/j.chom.2013.08.006] [Cited by in Crossref: 249] [Cited by in F6Publishing: 241] [Article Influence: 31.1] [Reference Citation Analysis]
163 Ogunbayo GO, Bidwell K, Misumida N, Ha LD, Abdel-Latif A, Elayi CS, Smyth S, Messerli AW. Sex differences in the contemporary management of HIV patients admitted for acute myocardial infarction. Clin Cardiol 2018;41:488-93. [PMID: 29672871 DOI: 10.1002/clc.22902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
164 Alqaqa A, Suleiman A, Birnhak S, Tariq S, Sison R, Hamdan A, DeBari VA, Shamoon F. Cardiac sequelae of human immunodeficiency virus disease. Am J Med Sci 2014;348:82-6. [PMID: 24743404 DOI: 10.1097/MAJ.0000000000000258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Albaeni A, Harris C, Eid SM, Abougergi MS, Wright SM. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction. Coron Artery Dis 2017;28:239-45. [PMID: 28288008 DOI: 10.1097/MCA.0000000000000488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
166 Bittencourt MS. Estimating Cardiovascular Risk in HIV-Infected Patients. Arq Bras Cardiol 2020;114:76-7. [PMID: 32049173 DOI: 10.36660/abc.20190747] [Reference Citation Analysis]
167 Robert R, Cottin Y, Potard V, Mary-Krause M, Lang S, Teiger E, Collet JP, Chauvet-Droit M, Ederhy S, Soulat-Dufour L, Ancedy Y, Adavane-Scheuble S, Nhan P, Steg PG, Funck-Brentano C, Costagliola D, Cohen A, Boccara F; on behalf the PACS-HIV Investigators. Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary Syndrome. Circ Cardiovasc Interv 2022;15:e011945. [PMID: 35535605 DOI: 10.1161/CIRCINTERVENTIONS.122.011945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Moran CA, Southmayd G, Devireddy CM, Quyyumi AA, Ofotokun I, Liberman HA, Jaber W, Sheth AN. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome. AIDS 2020;34:81-90. [PMID: 31634195 DOI: 10.1097/QAD.0000000000002393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
169 Dominick L, Midgley N, Swart LM, Sprake D, Deshpande G, Laher I, Joseph D, Teer E, Essop MF. HIV-related cardiovascular diseases: the search for a unifying hypothesis. Am J Physiol Heart Circ Physiol 2020;318:H731-46. [PMID: 32083970 DOI: 10.1152/ajpheart.00549.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
170 Borlaug BA. Moving beyond cardio-centricity in heart failure risk stratification. Circulation 2015;132:1602-3. [PMID: 26358262 DOI: 10.1161/CIRCULATIONAHA.115.018951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Goulenok T, Boyd A, Larsen M, Fastenackels S, Boccara F, Meynard JL, Hadour N, Samri A, Desvarieux M, Autran B, Appay V, Girard PM, Sauce D; CHIC Study group. Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients. AIDS 2015;29:287-93. [PMID: 25686677 DOI: 10.1097/QAD.0000000000000539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
172 Moh DR, Badjé A, Ello NF, N'takpé JB, Anzouan-Kacou JB, Kouamé GM, Ackoundzé S, Boccara F, Ba-Gomis O, Eholié SP, Anglaret X, Danel C. [Aortic aneurism dissection in an adult patient with tuberculosis infected with HIV-1 during immune reconstitution inflammatory syndrome]. Pan Afr Med J 2018;31:10. [PMID: 30918538 DOI: 10.11604/pamj.2018.31.10.12824] [Reference Citation Analysis]
173 Pulliam L, Calosing C, Sun B, Grunfeld C, Rempel H. Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production. J Interferon Cytokine Res 2014;34:822-8. [PMID: 24731171 DOI: 10.1089/jir.2013.0152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
174 Boccara F, Kumar PN, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS; BEIJERINCK Investigators. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study. J Am Coll Cardiol 2020;75:2570-84. [PMID: 32234462 DOI: 10.1016/j.jacc.2020.03.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
175 Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ; INSIGHT SMART Study Group. Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study. J Electrocardiol 2014;47:264-71. [PMID: 24406207 DOI: 10.1016/j.jelectrocard.2013.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
176 Maia-Leite LH, Catez E, Boyd A, Haddour N, Curjol A, Lang S, Nuernberg M, Duvivier C, Desvarieux M, Kirstetter M, Girard PM, Cohen A, Boccara F. Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals: results from the EVAS-HIV (EValuation of Aortic Stiffness in HIV-infected individuals). J Hypertens 2016;34:1338-46. [PMID: 27137177 DOI: 10.1097/HJH.0000000000000957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
177 Gao P, Rong HH, Lu T, Tang G, Si LY, Lederer JA, Xiong W. The CD4/CD8 ratio is associated with coronary artery disease (CAD) in elderly Chinese patients. Int Immunopharmacol 2017;42:39-43. [PMID: 27866071 DOI: 10.1016/j.intimp.2016.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
178 Woldu M, Minzi O, Shibeshi W, Shewaamare A, Engidawork E. Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study. PLoS One 2021;16:e0260109. [PMID: 34843544 DOI: 10.1371/journal.pone.0260109] [Reference Citation Analysis]
179 Feijoo MQ, Toro R, López Vazquez de la Torre M, Lennie V, Arce C, Moreno V, Valencia E, Vispo E, Almería C, Mangas A, Carbonero LM. Relationship between endothelin-1 levels and pulmonary arterial hypertension in HIV-infected patients. AIDS 2014;28:2693-9. [PMID: 25493595 DOI: 10.1097/QAD.0000000000000470] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
180 Thottian AG, Mallick S, Venkatesulu B, Kumar R, Haresh K, Gupta S, Sharma DN, Julka PK, Rath GK. Surviving Triple Trouble: Synchronous Breast and Cervical Cancer, HIV Infection and Myocardial Infarction. Breast J 2017;23:731-5. [PMID: 27886418 DOI: 10.1111/tbj.12718] [Reference Citation Analysis]
181 Hays AG, Schär M, Barditch-Crovo P, Bagchi S, Bonanno G, Meyer J, Afework Y, Streeb V, Stradley S, Kelly S, Anders NM, Margolick JB, Lai S, Gerstenblith G, Weiss RG. A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV. AIDS 2021;35:1041-50. [PMID: 33587443 DOI: 10.1097/QAD.0000000000002845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
182 Barakat MG, Arora RR. Coronary Artery Disease in the Human Immunodeficiency Virus Seropositive Population. American Journal of Therapeutics 2016;23:e224-31. [DOI: 10.1097/mjt.0b013e3182973924] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
183 Soliman EZ, Sharma S, Arastéh K, Wohl D, Achhra A, Tambussi G, O'Connor J, Stein JH, Duprez DA, Neaton JD, Phillips A; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med 2015;16 Suppl 1:46-54. [PMID: 25711323 DOI: 10.1111/hiv.12233] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]